Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia Provided by GlobeNewswire Jul 8, 2025, 5:00:00 AM ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Review the current Recursion Pharmaceuticals Inc Class A (RXRX:XNAS) dividend yield and history to decide if RXRX is the best investment for you.

Find the latest institutional holdings data for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) including shareholders, ownership summaries, and holding activities at Nasdaq.com.

View the most recent data and latest information on option chains for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) at Nasdaq.com.

Welcome to the Money blog, Sky News' personal finance and consumer hub. Today, our weekend long read looks at parents who charge their children rent - including one seven-year-old who pays keep ...

Welcome to the Money blog, Sky News' personal finance and consumer hub. Today, almost one million people are due a refund from HMRC - we explain how to check if you're due on. Plus, we report on ...